Go Pro
TSE:FTS

Fortis Q3 2024 Earnings Report

Fortis logo
C$77.02 +0.45 (+0.59%)
As of 12:23 PM Eastern

Fortis EPS Results

Actual EPS
C$0.85
Consensus EPS
C$0.81
Beat/Miss
Beat by +C$0.04
One Year Ago EPS
C$0.84

Fortis Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Fortis Announcement Details

Quarter
Q3 2024
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Fortis Earnings Headlines

Public market insider buying at Fortis (FTS)
FDA Momentum is Building Around NNVC!
NanoViricides (NYSE: NNVC) just received regulatory approval to begin a Phase II trial of NV-387 Oral Gummies for Ebola in the DRC, now the country's largest outbreak on record with over 4,100 cases. NV-387 uses a host-mimetic nanoviricide platform designed to trap and neutralize viruses. Noble Capital Markets recently initiated coverage on NNVC with an Outperform rating and a $6 price target.tc pixel
Fortis Drops $5: Time to Buy the Dip?
See More Fortis Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Fortis? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Fortis and other key companies, straight to your email.

About Fortis

Fortis (TSE:FTS) owns and operates 10 utility transmission and distribution assets in Canada and the United States, serving more than 3.4 million electricity and gas customers. The company has smaller stakes in electricity generation and several Caribbean utilities. ITC operates electric transmission in seven U.S. states, with more than 16,000 miles of high-voltage transmission lines in operation serving a peak load in excess of 23 gigawatts.

View Fortis Profile